Literature DB >> 1665496

A comparison of spreading and motility behaviour of 8701-BC breast carcinoma cells on type I, I-trimer and type V collagen substrata. Evidence for a permissive effect of type I-trimer collagen on cell locomotion.

C Luparello1, P Sheterline, I Pucci-Minafra, S Minafra.   

Abstract

Ductal infiltrating carcinoma (d.i.c.) of human breast is a highly invasive neoplasm characterized by enhanced deposition of collagen. Paradoxically, enhanced collagen deposition is not correlated with inhibition of the migration of tumour cells into the host tissue. d.i.c. is characterized by the reappearance of 'embryonic' type I-trimer collagen and an increase in type V collagen content in the matrix. The effects of these two collagen types were compared with type I collagen as culture substrata on the spreading pattern, cytoskeletal organization and motile behaviour of 8701-BC breast carcinoma cells using rhodamine-phalloidin staining, a DNAase I-competition assay, scanning electron microscopy and time-lapse video-microscopy. Cells grown on type I collagen were stationary, showing a well-spread morphology and an extensive stress fibre pattern. Cells grown on type V collagen were also stationary, but displayed a poorly spread and elongated morphology. In contrast, cells grown on trimer collagen were motile and displayed a compact morphology and a reduced content of stress fibres. Both single-cell and group motility were detectable on trimer collagen substratum. These data are consistent with the existence of two opposite local signals, type I-trimer and type V collagens, which may confer a more or a less metastatic phenotype on breast carcinoma cells. Moreover, the synthesis of trimer collagen in d.i.c. is conceivably instrumental in providing new stromal pathways permitting tumour cells to infiltrate the host tissue.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1665496     DOI: 10.1242/jcs.100.1.179

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  7 in total

1.  Matrix components and behavior of human adenocarcinoma cells.

Authors:  J Turnay; N Olmo; M T López-Conejo; M A Lizarbe
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-10       Impact factor: 2.416

2.  Carcinomas contain a matrix metalloproteinase-resistant isoform of type I collagen exerting selective support to invasion.

Authors:  Elena Makareeva; Sejin Han; Juan Carlos Vera; Dan L Sackett; Kenn Holmbeck; Charlotte L Phillips; Robert Visse; Hideaki Nagase; Sergey Leikin
Journal:  Cancer Res       Date:  2010-05-11       Impact factor: 12.701

3.  Characterization and analysis of human chordoma cell lines.

Authors:  Cao Yang; Francis J Hornicek; Kirkham B Wood; Joseph H Schwab; Edwin Choy; John Iafrate; Andrew Rosenberg; G Petur Nielsen; Ramnik J Xavier; Henry Mankin; Zhenfeng Duan
Journal:  Spine (Phila Pa 1976)       Date:  2010-06-01       Impact factor: 3.468

Review 4.  Collagen induced MMP-2 activation in human breast cancer.

Authors:  E W Thompson; M Yu; J Bueno; L Jin; S N Maiti; F L Palao-Marco; H Pulyaeva; J W Tamborlane; R Tirgari; I Wapnir
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

5.  Autoimmune pancreatocholangitis, non-autoimmune pancreatitis and primary sclerosing cholangitis: a comparative morphological and immunological analysis.

Authors:  Irene Esposito; Diana Born; Frank Bergmann; Thomas Longerich; Thilo Welsch; Nathalia A Giese; Markus W Büchler; Jörg Kleeff; Helmut Friess; Peter Schirmacher
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240

6.  Tumor cell-collagen interactions: Identification and semi-quantitative evaluation of selectively-expressed genes by combination of differential display- and multiplex-PCR.

Authors:  Rosalia Sirchia; Valentina Ciacciofera; Claudio Luparello
Journal:  Biol Proced Online       Date:  2003-11-24       Impact factor: 3.244

7.  An integrative histopathologic clustering model based on immuno-matrix elements to predict the risk of death in malignant mesothelioma.

Authors:  Marcelo Luiz Balancin; Walcy Rosolia Teodoro; Cecilia Farhat; Tomas Jurandir de Miranda; Aline Kawassaki Assato; Neila Aparecida de Souza Silva; Ana Paula Velosa; Roberto Falzoni; Alexandre Muxfeldt Ab'Saber; Anja C Roden; Vera Luiza Capelozzi
Journal:  Cancer Med       Date:  2020-05-11       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.